This is a routine insider intent-to-sell filing by a director. The dollar amount is immaterial relative to market cap. No immediate trading action warranted. Monitor for any subsequent Form 4 filings to confirm execution.
Price Chart
Executive Summary
Director Garen G. Bohlin filed a Form 144 notice of intent to sell 8,700 shares of Collegium Pharmaceutical common stock, valued at approximately $323,491. The sale is planned through Fidelity Brokerage Services LLC and relates to shares acquired via a 2016 option grant. While the filing itself is routine, the historical performance data shows past bullish calls on COLL have significantly underperformed, suggesting caution.
Key Facts
- Director Garen G. Bohlin filed Form 144 to sell 8,700 shares.
- Estimated sale value: $323,491.
- Shares relate to a 2016 option grant.
- Sale to be executed through Fidelity Brokerage Services LLC.
- Filing date: May 11, 2026.
Financial Impact
Sale of 8,700 shares valued at ~$323,491, representing a small fraction of the company's $1.2B market cap.
Risk Factors
- Insider selling may signal lack of confidence, but this is a small, routine sale by a director, not a C-suite officer.
- Historical performance data shows past bullish calls on COLL have been wrong, but this filing is neutral and does not change the fundamental outlook.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-003457 |
| Document: 0001959173-26-003457-index.html | 0001959173-26-003457 |
| Document: 0001959173-26-003457.txt | 0001959173-26-003457 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 19, 2026 6w ago | Court Ruling | $28.74 $22.38 | ▼ −22.13% | ▼ −20.18% | $22.07 (−23.21%) |
Aug 13, 2026 7w ago | 8-K | $28.15 $22.75 | ▼ −19.18% | ▼ −17.44% | $22.07 (−21.60%) |
Aug 6, 2026 8w ago | 8-K | $29.11 $23.70 | ▼ −18.58% | ▼ −19.18% | $22.07 (−24.18%) |
May 15, 2026 19w ago | Insider Cluster | $33.65 $34.65 | ▲ +2.97% | ▲ +1.39% | $22.07 (−34.41%) |
May 12, 2026 20w ago | Press Release | $35.69 $34.80 | ▼ −2.49% | ▼ −0.77% | $22.07 (−38.16%) |
May 11, 2026 20w ago | 144 | $35.81 $34.40 | ▼ −3.94% | ▼ −3.63% | $22.07 (−38.37%) |
Apr 23, 2026 23w ago | Press Release | $32.28 $34.22 | ▲ +6.01% | ▲ +1.38% | $22.07 (−31.63%) |
Apr 7, 2026 25w ago | 8-K | $33.43 $35.32 | ▲ +5.65% | ▼ −2.89% | $22.07 (−33.98%) |
Mar 19, 2026 28w ago | Press Release | $36.30 $34.41 | ▼ −5.21% | ▼ −12.83% | $22.07 (−39.20%) |
Mar 3, 2026 30w ago | Press Release | $39.99 $33.07 | ▼ −17.30% | ▼ −12.90% | $22.07 (−44.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access